A University of Florida professor is hoping to position GaN devices as robust and inexpensive electrical monitors for diabetes, renal failure and prostate cancer. Electronic detection of so-called biomarker molecules could accelerate disease diagnosis, and GaN transistors are one of the cheapest options available to achieve this. That's what Fan Ren of the University of Florida reckons, and he’s recently made his case by detecting a biomarker that signals acute renal failure down to 1 ng/ml. At this level, the researchers say that their device could be useful for preclinical and clinical applications. In a November 26 Applied Physics Letters paper, Ren and his collaborators modified a GaN high-electron mobility transistor (HEMT) from Nitronex by attaching kidney injury molecule-1 (KIM-1) antibodies to it. When KIM-1 is exposed to the transistor it then remains attached to the antibodies, affecting electron mobility and hence the current passing through the HEMT. KIM-1 is a molecule...